Literature DB >> 2890206

Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease.

P H St George-Hyslop1, R E Tanzi, R J Polinsky, R L Neve, D Pollen, D Drachman, J Growdon, L A Cupples, L Nee, R H Myers.   

Abstract

The possibility that Alzheimer's disease (AD) is caused by overexpression or duplication of one or more genes on chromosome 21 has been raised by the observation of AD-like neuropathologic changes in individuals with Down syndrome and by the mapping of both the defect for familial AD and the amyloid beta protein gene to this autosome. Possible duplication on chromosome 21 was investigated in both familial and sporadic AD by means of restriction fragment length polymorphisms for the amyloid and SODI loci, as well as for DNA markers in the vicinity of the familial AD defect and in the critical Down syndrome region of chromosome 21. No evidence of increased DNA dosage was observed in either brain or leukocytes of patients with inherited or sporadic forms of AD. Duplication of these regions is therefore not a frequent event in either form of AD. Furthermore, no significant allelic association was detected between AD and any of the loci, including the amyloid and SODI genes, providing no support for the hypothesis that defects in these specific genes are the primary cause of AD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890206     DOI: 10.1126/science.2890206

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  Widespread expression of amyloid beta-protein precursor gene in rat brain.

Authors:  S Mita; E A Schon; J Herbert
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

2.  Molecular and cytogenetic characterization of a de novo t(5p;21q) in a patient previously diagnosed as monosomy 21.

Authors:  M C Phelan; C C Morton; R E Stevenson; R E Tanzi; G D Stewart; P C Watkins; J F Gusella; J A Amos
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

Review 3.  Alzheimer's disease--neuropathological aspects.

Authors:  C Bergeron
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

4.  Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease.

Authors:  G A Higgins; D A Lewis; S Bahmanyar; D Goldgaber; D C Gajdusek; W G Young; J H Morrison; M C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  Evidence for a membrane defect in Alzheimer disease brain.

Authors:  R M Nitsch; J K Blusztajn; A G Pittas; B E Slack; J H Growdon; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 6.  The genomically mosaic brain: aneuploidy and more in neural diversity and disease.

Authors:  Diane M Bushman; Jerold Chun
Journal:  Semin Cell Dev Biol       Date:  2013-03-04       Impact factor: 7.727

7.  What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?

Authors:  Robyn A Wallace; Arthur J Dalton
Journal:  Alzheimers Res Ther       Date:  2011-04-19       Impact factor: 6.982

8.  Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains.

Authors:  Diane M Bushman; Gwendolyn E Kaeser; Benjamin Siddoway; Jurgen W Westra; Richard R Rivera; Stevens K Rehen; Yun C Yung; Jerold Chun
Journal:  Elife       Date:  2015-02-04       Impact factor: 8.140

9.  Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice.

Authors:  D O Wirak; R Bayney; C A Kundel; A Lee; G A Scangos; B D Trapp; A J Unterbeck
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

Review 10.  Neuronal aneuploidy in health and disease: a cytomic approach to understand the molecular individuality of neurons.

Authors:  Thomas Arendt; Birgit Mosch; Markus Morawski
Journal:  Int J Mol Sci       Date:  2009-04-15       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.